Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8227210 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 8 Pages |
Abstract
This pilot trial suggested that phenylbutyrate mouthwash significantly decreased the impact of OM in HNC patients receiving RT or chemoradiotherapy and did not confront the tumor control. Larger Phase II randomized trials are needed to confirm these results.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sang-Hue M.D., Ling-Wei M.D., Yi-Hsien M.D., Yee-Min M.D., Ph.D., Yih-Lin M.D., M.Sc.,